Page last updated: 2024-10-31

molsidomine and Angiospasm, Intracranial

molsidomine has been researched along with Angiospasm, Intracranial in 3 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
" In this study, the authors examined the effects of treatment with the NO donor molsidomine with regard to decreasing the incidence of spasm-related delayed brain infarctions and improving clinical outcome in patients with SAH."7.83Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. ( Brüning, R; Ehlert, A; Heindel, W; Hesselmann, V; Jacobs, AH; Manthei, G; Pluta, RM; Ringelstein, EB; Schmidt, C; Stummer, W; Wölfer, J, 2016)
" In this study, the authors examined the effects of treatment with the NO donor molsidomine with regard to decreasing the incidence of spasm-related delayed brain infarctions and improving clinical outcome in patients with SAH."3.83Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. ( Brüning, R; Ehlert, A; Heindel, W; Hesselmann, V; Jacobs, AH; Manthei, G; Pluta, RM; Ringelstein, EB; Schmidt, C; Stummer, W; Wölfer, J, 2016)
"Within 48 hours, the patient developed cerebral vasospasm with DCI."2.53A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review. ( Bein, B; Ehlert, A; Hesselmann, V; Manthei, G; Mathias, K; Pluta, R, 2016)
"Delayed cerebral ischemia (DCI) occurred only during loose, low-dose or interrupted treatment (17% vs."1.56Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage. ( Ehlert, A; Ehlert-Gamm, A; Flack, J; Gerss, J; Gessert, M; Hesselmann, V; Manthei, G; Starekova, J, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ehlert, A3
Starekova, J1
Manthei, G3
Ehlert-Gamm, A1
Flack, J1
Gessert, M1
Gerss, J1
Hesselmann, V3
Schmidt, C1
Wölfer, J1
Jacobs, AH1
Brüning, R1
Heindel, W1
Ringelstein, EB1
Stummer, W1
Pluta, RM1
Mathias, K1
Bein, B1
Pluta, R1

Reviews

1 review available for molsidomine and Angiospasm, Intracranial

ArticleYear
A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review.
    World neurosurgery, 2016, Volume: 91

    Topics: Aged; Female; Glasgow Coma Scale; Glasgow Outcome Scale; Humans; Injections, Intravenous; Injections

2016

Other Studies

2 other studies available for molsidomine and Angiospasm, Intracranial

ArticleYear
Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage.
    Neurocritical care, 2020, Volume: 32, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aneurysm, Ruptured; Brain Ischemia; Feasibility Studies; Female; Hum

2020
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Journal of neurosurgery, 2016, Volume: 124, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Infarction; Brain Ischemia; Drug Therapy, Combinat

2016